What is CRMD's current stock price?

As of now, CRMD is trading at $11.31, with a daily change of +0.98%.

What are the risks associated with CRMD stock?

CRMD Key risk is its Moderate Risk Level, .

What is CRMD next earnings date?

CRMD next earnings report is scheduled for Oct 29, 2025.

Market Overview Trending Stocks Stock Screener Trade Insights

Top Rated Stocks Most Active Stocks Top Potential Stocks Top Momentum Stocks Earnings Calendar Leaderboard

About Us Log In Sign Up Plans & Pricing Contact Us Terms of Use Privacy Policy

Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist

CRMD Stock Analysis & IQ Rating | CorMedix

CRMD

CorMedix

$11.31

+$0.11 | +0.98%

Create Alerts

Overview

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Earnings

Headlines

52W High

$ 17.43

MKT CAP

$ 844.28M

52W Low

$ 5.6

VOL

$ 1.52M

P/E Ratio

15.15

AVG VOL

$ 2.64M

RSI

49.70

TREND

Downtrend

CRMD Stock IQ

Login to see CorMedix (CRMD) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

CRMD Target Price

Login to display

Strengths

CRMD Rewards

Earnings are forecast to grow

CRMD Rewards

Trading below its fair value

CRMD Rewards

Outperform the market

Chart

$11.3 (+0.09%)

$11.77 (-3.91%)

$12.61 (-10.31%)

$10.32 (+9.59%)

1year

6month

3month

1month

CRMD Risk Level

CRMD has Moderate Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk

Risks Indicators

Beta greater than 1.0

LOW

HIGH

CRMD Analysts Opinion

CRMD overall standing based on key factors, offering insights into analysts perspectives and market expectations.
menu Hover over the category for more information

CRMD Analysts Opinion

CRMD Analysts opinion is positive and also has improved from the past 3 months

CRMD Street Consensus

Analysts perspectives on the stock desirability, trend direction, and growth potential.

77%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

100%

33%

100%

CRMD Street Opinion

CRMD Street view is extremely bullish and have positive views on the near-term outlook

CRMD Performance Sentiment

Sentiments overview associated with CRMD events and the stock performance.

77%

23%

Positive

Negative

10 out of 13
events present

3 out of 13
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Technical Price Levels

Average key support and resistance price levels.

Login to display

Support
Price

$11.03

Resistance
Price

$10.08

Current Price Range

$14.83

Show methods +

CRMD Earnings

The TTM reflects 12-month period, providing review of CRMD financial performance.

Millions of Dollars

TTM

2024

2023

CAGR

Total Revenue

121

43

-

Cost of Revenue

5

3

-

Gross Profit

116

40

-

Operating Exp

67

63

49

+16.93%

Operating Inc

49

-22

-49

-

Net Interest Inc

2

3

-18.35%

Interest Exp

-

Interest Inc

2

3

-18.35%

Other Inc Exp

-

EPS Growth

0.80

-0.30

-0.91

-

CRMD Financial Health

The company financial health has shown minor improvement, but significant issues remain

Financial Score

2.82

Next Earnings Date: Oct 29, 2025

Linked to CRMD

IQ

Close Price

Change

TLPH

N/A

1.14

-3.39%

CRMD Latest Analysis +

RBC Capital Maintains CorMedix (CRMD) Outperform Recommendation. Fintel reports that on October 21 2025 RBC Capital maintained coverage of CorMedix (NasdaqGM:CRMD) with a Outperform recommendation. Analyst Price Forecast Suggests 79.56% Upside

Wed Oct 22, 2025

$11.20 | -3.86%

Potential

Rating

Beyond The Numbers: 4 Analysts Discuss Cormedix Stock. Cormedix (NASDAQ:CRMD) underwent analysis by 4 analysts in the last quarter revealing a spectrum of viewpoints from ish to bearish.The following table summarizes their recent ratings shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.2200001000100000100010000In the assessment of 12-month price targets analysts unveil insights for Cormedix presenting an average target of $18.75 a high

Tue Oct 21, 2025

$11.65 | -4.19%

Activity

Momentum

Earnings Estimates Rising for CorMedix (CRMD): Will It Gain?. CorMedix (CRMD) shares have started gaining and might continue moving higher in the near term as indicated by solid earnings estimate revisions.

Tue Oct 21, 2025

$11.65 | -4.19%

Earnings

Wall Street Analysts See a 68.59% Upside in CorMedix (CRMD): Can the Stock Really Move This High?. The average of price targets set by Wall Street analysts indicates a potential upside of 68.6% in CorMedix (CRMD). While the effectiveness of this highly sought-after metric is questionable the positive trend in earnings estimate revisions might translate into an upside in the stock.

Tue Oct 21, 2025

$11.65 | -4.19%

Potential

D. Boral Capital Upgrades CorMedix (CRMD). Fintel reports that on October 20 2025 D. Boral Capital upgraded their outlook for CorMedix (NasdaqGM:CRMD) from Hold to Buy. Analyst Price Forecast Suggests 71.96% Upside

Tue Oct 21, 2025

$11.65 | -4.19%

Potential

Rating

How Will DefenCath Aid CRMDs Top Line in the Upcoming Q3 Results?. CorMedixs DefenCath the first FDA-approved antimicrobial catheter lock is expected to drive Q3 growth as new Melinta drugs add to momentum.

Mon Oct 20, 2025

$12.16 | +19.01%

Activity

CorMedix Inc. Announces Preliminary Third Quarter 2025 Results and Raises 2025 Net Revenue Guidance. ‒ Q3 2025 Unaudited Pro Forma Net Revenue of more than $125 million ‒

Mon Oct 20, 2025

$12.16 | +19.01%

Potential

CorMedix Stock Plunges 16% in a Month: Should Investors Buy the Dip?. CRMD shares slip 16% but rising DefenCath sales and the Melinta deal can set the stage for renewed growth.

Tue Oct 14, 2025

$10.54 | -0.38%

Momentum

CorMedix files to sell 6.32M shares of common stock for holders.

Tue Oct 7, 2025

$11.18 | -3.29%

Activity

FAQ About CRMD Stock Insights

What is CRMD current stock price?

What are CRMD stock strengths?

What risks are associated with CRMD stock?

When is CRMD next earnings report?

What is CRMD market cap and volume?

What is CRMD's current Stock IQ?

Should I buy CRMD stock right now?

Is CRMD a Strong Buy right now?

What does a 'Strong Buy' rating mean for CRMD?

What does a 'Strong Sell' rating mean for CRMD?

What factors influence CRMD's Stock IQ?

Explore our CRMD Stock insights

In-Depth Market Analysis and Trends
Expert Insights on Market Dynamics
Tailored CRMD Stock Strategies
Effective Risk Management

FIND US ON

Receive our CRMD Daily Alerts

Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

CRMD

CorMedix

Current Price

$11.31

+$0.11 | +0.98%

52W High

$ 17.43

MKT CAP

$ 844.28M

52W Low

$ 5.6

VOL

$ 1.52M

P/E Ratio

15.15

AVG VOL

$ 2.64M

RSI

49.70

TREND

Downtrend

Create Alerts

Overview

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Earnings

Target Price

Login to display

Not Enough Information

Stock Insights

Strengths

CRMD Rewards

Earnings are forecast to grow

CRMD Rewards

Trading below its fair value

CRMD Rewards

Outperform the market

Linked to CRMD

Symbol

IQ

Close

Change

TLPH

N/A

1.14

-3.39%

CRMD Stock IQ

Login to unlock CorMedix (CRMD) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

Chart

$11.3 (+0.09%)

$11.77 (-3.91%)

$12.61 (-10.31%)

$10.32 (+9.59%)

1year

6month

3month

1month

CRMD Analysts Opinion

CRMD Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
menu Hover over the category for more information

CRMD Analysts Opinion

CRMD Analysts opinion is positive and also has improved from the past 3 months

CRMD Street Consensus

Analysts perspectives on the stock desirability, trend direction, and growth potential.

77%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

100%

33%

100%

CRMD Street Opinion

CRMD Street view is extremely bullish and have positive views on the near-term outlook

CRMD Risk Level

CRMD has Moderate Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk

Risks Indicators

Beta greater than 1.0

LOW

HIGH

CRMD Performance Sentiment

Sentiments overview associated with CRMD events and the stock performance.

77%

23%

Positive

Negative

10 out of 13
events present

3 out of 13
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Technical Price Levels

Average key support and resistance price levels.

Login to display

Support
Price

$11.03

Resistance
Price

$10.08

Current Price Range

$14.83

Show methods +

CRMD Earnings

The TTM data reflects the most recent 12-month period, providing overview of CRMD financial performance.

Millions of Dollars

TTM

2024

2023

CAGR

Total Revenue

121

43

-

Cost of Revenue

5

3

-

Gross Profit

116

40

-

Operating Exp

67

63

49

+16.93%

Operating Inc

49

-22

-49

-

Net Interest Inc

2

3

-18.35%

Interest Exp

-

Interest Inc

2

3

-18.35%

Other Inc Exp

-

EPS Growth

0.80

-0.30

-0.91

-

CRMD Financial Health

The company financial health has shown minor improvement, but significant issues remain

Financial Score

2.82

Next Earnings Date: Oct 29, 2025

CRMD Latest Analysis

RBC Capital Maintains CorMedix (CRMD) Outperform Recommendation. Fintel reports that on October 21 2025 RBC Capital maintained coverage of CorMedix (NasdaqGM:CRMD) with a Outperform recommendation. Analyst Price Forecast Suggests 79.56% Upside

Wed Oct 22, 2025

$11.20 | -3.86%

Potential

Rating

Beyond The Numbers: 4 Analysts Discuss Cormedix Stock. Cormedix (NASDAQ:CRMD) underwent analysis by 4 analysts in the last quarter revealing a spectrum of viewpoints from ish to bearish.The following table summarizes their recent ratings shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.2200001000100000100010000In the assessment of 12-month price targets analysts unveil insights for Cormedix presenting an average target of $18.75 a high

Tue Oct 21, 2025

$11.65 | -4.19%

Activity

Momentum

Earnings Estimates Rising for CorMedix (CRMD): Will It Gain?. CorMedix (CRMD) shares have started gaining and might continue moving higher in the near term as indicated by solid earnings estimate revisions.

Tue Oct 21, 2025

$11.65 | -4.19%

Earnings

Wall Street Analysts See a 68.59% Upside in CorMedix (CRMD): Can the Stock Really Move This High?. The average of price targets set by Wall Street analysts indicates a potential upside of 68.6% in CorMedix (CRMD). While the effectiveness of this highly sought-after metric is questionable the positive trend in earnings estimate revisions might translate into an upside in the stock.

Tue Oct 21, 2025

$11.65 | -4.19%

Potential

D. Boral Capital Upgrades CorMedix (CRMD). Fintel reports that on October 20 2025 D. Boral Capital upgraded their outlook for CorMedix (NasdaqGM:CRMD) from Hold to Buy. Analyst Price Forecast Suggests 71.96% Upside

Tue Oct 21, 2025

$11.65 | -4.19%

Potential

Rating

How Will DefenCath Aid CRMDs Top Line in the Upcoming Q3 Results?. CorMedixs DefenCath the first FDA-approved antimicrobial catheter lock is expected to drive Q3 growth as new Melinta drugs add to momentum.

Mon Oct 20, 2025

$12.16 | +19.01%

Activity

CorMedix Inc. Announces Preliminary Third Quarter 2025 Results and Raises 2025 Net Revenue Guidance. ‒ Q3 2025 Unaudited Pro Forma Net Revenue of more than $125 million ‒

Mon Oct 20, 2025

$12.16 | +19.01%

Potential

CorMedix Stock Plunges 16% in a Month: Should Investors Buy the Dip?. CRMD shares slip 16% but rising DefenCath sales and the Melinta deal can set the stage for renewed growth.

Tue Oct 14, 2025

$10.54 | -0.38%

Momentum

CorMedix files to sell 6.32M shares of common stock for holders.

Tue Oct 7, 2025

$11.18 | -3.29%

Activity

Discover CRMD Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends, and the future potential of CRMD. We're here to help you make informed investment decisions today.

FIND US ON

Receive our CRMD Daily Alerts

Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

CRMD Stock trends

CRMD Stock performance

CRMD Stock analysis

CRMD investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner Insights

Financial Reports

Disclaimer: Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor. The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses. Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing CRMD

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence, and cutting-edge intelligence.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing CRMD

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence, and cutting-edge intelligence.

CRMD Stock Analysis & IQ Rating | CorMedix

CRMD Stock IQ

CRMD Target Price

CRMD Risk Level

CRMD Analysts Opinion

CRMD Street Consensus

CRMD Performance Sentiment

Technical Price Levels

CRMD Financial Health

Explore our CRMD Stock insights

Receive our CRMD Daily Alerts

CRMD Stock IQ

CRMD Street Consensus

CRMD Risk Level

Technical Price Levels

Discover CRMD Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends, and the future potential of CRMD. We're here to help you make informed investment decisions today.

Receive our CRMD Daily Alerts

CRMD Runner Alarm